ceftobiprole plus placebo + linezolid plus ceftazidime
Phase 3Completed 0 watching 0 views this week📈 Rising
72
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Pneumonia
Conditions
Pneumonia
Trial Timeline
Nov 1, 2005 → May 1, 2007
NCT ID
NCT00229008About ceftobiprole plus placebo + linezolid plus ceftazidime
ceftobiprole plus placebo + linezolid plus ceftazidime is a phase 3 stage product being developed by Basilea Pharmaceutica for Pneumonia. The current trial status is completed. This product is registered under clinical trial identifier NCT00229008. Target conditions include Pneumonia.
Hype Score Breakdown
Clinical
27
Activity
18
Company
5
Novelty
9
Community
10
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00229008 | Phase 3 | Completed |
| NCT00210964 | Phase 3 | Completed |
Competing Products
20 competing products in Pneumonia